Boehringer, Eli Lilly to launch diabetes drug in India
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India.
Original Article: Boehringer, Eli Lilly to launch diabetes drug in India
NEXT ARTICLE